Handelsbanken Fonder’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-42,200
Closed -$36K 1585
2023
Q1
$36K Hold
42,200
﹤0.01% 1559
2022
Q4
$39K Hold
42,200
﹤0.01% 1552
2022
Q3
$72K Hold
42,200
﹤0.01% 1548
2022
Q2
$90K Hold
42,200
﹤0.01% 1588
2022
Q1
$150K Hold
42,200
﹤0.01% 1665
2021
Q4
$157K Buy
+42,200
New +$259K ﹤0.01% 1728

Other funds holding CLOV

Handelsbanken Fonder's CLOV Position: Q2 2023 in Review

Handelsbanken Fonder sold out of Clover Health Investments (CLOV) in Q2 2023, closing a stake of 42,200 shares — an estimated $36K sold.

Handelsbanken Fonder first reported a position in CLOV in Q4 2021 and held it in 6 quarters. The position peaked at $157K in Q4 2021. 145 funds tracked by Wall St. Rank hold CLOV as of Q2 2023.

  • Handelsbanken Fonder reported no remaining Clover Health Investments position as of Q2 2023 after selling out during the quarter.
  • Handelsbanken Fonder sold 42,200 Clover Health Investments shares in Q2 2023, an estimated $36K.
  • Handelsbanken Fonder first reported a position in Clover Health Investments in Q4 2021 and held it in 6 quarters.
  • Handelsbanken Fonder's Clover Health Investments position peaked at $157K in Q4 2021.
  • 145 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2023.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.